Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Bridget Harris

Showing results (11-20 of 20) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 20 results.
Frontiers in Neurology|January 6, 2011
Report of a consensus meeting on human brain temperature after severe traumatic brain injury: its measurement and management during pyrexiaCharmaine Childs, Tadeusz Wieloch, Fiona Lecky, et al.
Scientific Reports|May 20, 2018
How does blood regulate cerebral temperatures during hypothermia?Stephen Blowers, Ian Marshall, Michael Thrippleton, et al.
Health Technology Assessment (Winchester, England)|September 1, 2018
Therapeutic hypothermia to reduce intracranial pressure after traumatic brain injury: the Eurotherm3235 RCTPeter Jd Andrews, H Louise Sinclair, Aryelly Rodríguez, et al.
Trials|September 6, 2013
Study of therapeutic hypothermia (32 to 35°C) for intracranial pressure reduction after traumatic brain injury (the Eurotherm3235Trial): outcome of the pilot phase of the trialPeter J D Andrews, Louise H Sinclair, Bridget Harris, et al.
ERJ Open Research|February 22, 2021
What is important for people with nontuberculous mycobacterial disease? An EMBARC-ELF patient surveyMichal Shteinberg, Jeanette Boyd, Stefano Aliberti, et al.
The European Respiratory Journal|January 13, 2018
Cross-infection risk in patients with bronchiectasis: a position statement from the European Bronchiectasis Network (EMBARC), EMBARC/ELF patient advisory group and European Reference Network (ERN-Lung) Bronchiectasis NetworkJames D Chalmers, Felix C Ringshausen, Bridget Harris, et al.
Research Square|September 18, 2023
Implementation of an "Opt-Out" Tobacco Treatment Program in Six Hospitals in South CarolinaK Michael Cummings, Vincent Talbot, Avery Roberson, et al.
BMC Health Services Research|June 17, 2024
Implementation of an "opt-out" tobacco treatment program in six hospitals in South CarolinaK Michael Cummings, Vincent Talbot, Avery Roberson, et al.
The European Respiratory Journal|June 6, 2024
Diagnostic delay and access to care in bronchiectasis: data from the EMBARC/ELF patient surveyArietta Spinou, Marta Almagro, Bridget Harris, et al.
ERJ Open Research|March 11, 2026
Design and rationale of the AIR-NET trial: a randomised, open-label, multifactorial, multicentre, adaptive platform trial using a range of repurposed anti-inflammatory treatments to improve outcomes in patients with bronchiectasis within the EMBARC clinical research networkMerete B Long, Jaa Ming New, Jamie Stobo, et al.
Pageof 2

Showing results (11-20 of 20) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 20 results.
Frontiers in Neurology|January 6, 2011
Report of a consensus meeting on human brain temperature after severe traumatic brain injury: its measurement and management during pyrexiaCharmaine Childs, Tadeusz Wieloch, Fiona Lecky, et al.
Scientific Reports|May 20, 2018
How does blood regulate cerebral temperatures during hypothermia?Stephen Blowers, Ian Marshall, Michael Thrippleton, et al.
Health Technology Assessment (Winchester, England)|September 1, 2018
Therapeutic hypothermia to reduce intracranial pressure after traumatic brain injury: the Eurotherm3235 RCTPeter Jd Andrews, H Louise Sinclair, Aryelly Rodríguez, et al.
Trials|September 6, 2013
Study of therapeutic hypothermia (32 to 35°C) for intracranial pressure reduction after traumatic brain injury (the Eurotherm3235Trial): outcome of the pilot phase of the trialPeter J D Andrews, Louise H Sinclair, Bridget Harris, et al.
ERJ Open Research|February 22, 2021
What is important for people with nontuberculous mycobacterial disease? An EMBARC-ELF patient surveyMichal Shteinberg, Jeanette Boyd, Stefano Aliberti, et al.
The European Respiratory Journal|January 13, 2018
Cross-infection risk in patients with bronchiectasis: a position statement from the European Bronchiectasis Network (EMBARC), EMBARC/ELF patient advisory group and European Reference Network (ERN-Lung) Bronchiectasis NetworkJames D Chalmers, Felix C Ringshausen, Bridget Harris, et al.
Research Square|September 18, 2023
Implementation of an "Opt-Out" Tobacco Treatment Program in Six Hospitals in South CarolinaK Michael Cummings, Vincent Talbot, Avery Roberson, et al.
BMC Health Services Research|June 17, 2024
Implementation of an "opt-out" tobacco treatment program in six hospitals in South CarolinaK Michael Cummings, Vincent Talbot, Avery Roberson, et al.
The European Respiratory Journal|June 6, 2024
Diagnostic delay and access to care in bronchiectasis: data from the EMBARC/ELF patient surveyArietta Spinou, Marta Almagro, Bridget Harris, et al.
ERJ Open Research|March 11, 2026
Design and rationale of the AIR-NET trial: a randomised, open-label, multifactorial, multicentre, adaptive platform trial using a range of repurposed anti-inflammatory treatments to improve outcomes in patients with bronchiectasis within the EMBARC clinical research networkMerete B Long, Jaa Ming New, Jamie Stobo, et al.
Pageof 2